Search - Université de Rennes Access content directly

Filter your results

12 Results
authFullName_s : Amélie Moreau

Regulation of drug transporter mRNA expression by interferon-γ in primary human hepatocytes.

Marc Le Vee , Elodie Jouan , Amélie Moreau , Olivier Fardel
Fundamental & Clinical Pharmacology, 2011, 25 (1), pp.99-103. ⟨10.1111/j.1472-8206.2010.00822.x⟩
Journal articles istex hal-00680740v1
Image document

mRNA Expression and Activity of Nucleoside Transporters in Human Hepatoma HepaRG Cells

Abdullah Mayati , Amélie Moreau , Elodie Jouan , Marie Febvre-James , Claire Denizot et al.
Pharmaceutics, 2018, 10 (4), ⟨10.3390/pharmaceutics10040246⟩
Journal articles hal-01976472v1

Protein Kinase C-Independent Inhibition of Organic Cation Transporter 1 Activity by the Bisindolylmaleimide Ro 31-8220

Abdullah Mayati , Arnaud Bruyère , Amélie Moreau , Elodie Jouan , Claire Denizot et al.
PLoS ONE, 2015, 10 (12), pp.e0144667. ⟨10.1371/journal.pone.0144667⟩
Journal articles hal-01255837v1

Protein Kinases C-Mediated Regulations of Drug Transporter Activity, Localization and Expression

Abdullah Mayati , Amélie Moreau , Marc Le Vee , Bruno Stieger , Claire Denizot et al.
International Journal of Molecular Sciences, 2017, 18 (4), pp.764. ⟨10.3390/ijms18040764⟩
Journal articles hal-01516024v1

Functional expression and regulation of drug transporters in monolayer- and sandwich-cultured mouse hepatocytes.

Grégory Noel , Marc Le Vee , Amélie Moreau , Bruno Stieger , Yannick Parmentier et al.
European Journal of Pharmaceutical Sciences, 2013, 49 (1), pp.39-50. ⟨10.1016/j.ejps.2013.01.013⟩
Journal articles inserm-00823243v1

Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors

Elodie Jouan , Amélie Moreau , Arnaud Bruyere , Karima Alim , Claire Denizot et al.
European journal of drug metabolism and pharmacokinetics, 2021, 46 (5), pp.625-635. ⟨10.1007/s13318-021-00703-2⟩
Journal articles hal-03341320v1

Drug transporter expression in human macrophages.

Amélie Moreau , Marc Le Vee , Elodie Jouan , Yannick Parmentier , Olivier Fardel et al.
Fundamental & Clinical Pharmacology, 2011, 25 (6), pp.743-52. ⟨10.1111/j.1472-8206.2010.00913.x⟩
Journal articles istex hal-00873191v1
Image document

Protein kinase C-dependent regulation of human hepatic drug transporter expression

Abdullah Mayati , Marc Le Vee , Amélie Moreau , Elodie Jouan , Simon Bucher et al.
Biochemical Pharmacology, 2015, 98 (4), pp.703-717. ⟨10.1016/j.bcp.2015.10.007⟩
Journal articles hal-01216205v1
Image document

Inhibition of organic cation transporter 3 activity by tyrosine kinase inhibitors

Karima Alim , Amélie Moreau , Arnaud Bruyère , Elodie Jouan , Claire Denizot et al.
Fundamental & Clinical Pharmacology, 2021, ⟨10.1111/fcp.12657⟩
Journal articles hal-03134613v1

beta 2-adrenergic receptor-mediated in vitro regulation of human hepatic drug transporter expression by epinephrine

Abdullah Mayati , Amélie Moreau , Claire Denizot , Bruno Stieger , Yannick Parmentier et al.
European Journal of Pharmaceutical Sciences, 2017, 106, pp.302--312. ⟨10.1016/j.ejps.2017.06.010⟩
Journal articles hal-01578583v1
Image document

New insights in the in vitro characterisation and molecular modelling of the P-glycoprotein inhibitory promiscuity

Giovanni Bocci , Amélie Moreau , Philippe Vayer , Claire Denizot , Olivier Fardel et al.
European Journal of Pharmaceutical Sciences, 2018, 121 (30), pp.85-94. ⟨10.1016/j.ejps.2018.04.039⟩
Journal articles hal-01795811v3

Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes.

Marc Le Vee , Valérie Lecureur , Amélie Moreau , Bruno Stieger , Olivier Fardel et al.
Drug Metabolism and Disposition, 2009, 37 (11), pp.2228-35. ⟨10.1124/dmd.109.028035⟩
Journal articles hal-00673342v1